Macy's/$M
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Macy's
Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.
- Ticker
- $M
- Sector
- Consumer Essentials
- Primary listing
- NYSE
- Employees
- 90,134
- Headquarters
- New York, United States
- Website
- www.macysinc.com
Macy's Metrics
BasicAdvanced
$6.5B
9.01
$2.74
1.43
$0.76
3.10%
Price and volume
Market cap
$6.5B
Beta
1.43
52-week high
$26.59
52-week low
$16.69
Average daily volume
6.4M
Dividend rate
$0.76
Financial strength
Current ratio
1.59
Quick ratio
0.381
Long term debt to equity
1.033
Total debt to equity
1.033
Dividend payout ratio (TTM)
26.40%
Interest coverage (TTM)
9.34%
Profitability
EBITDA (TTM)
1,400
Gross margin (TTM)
40.28%
Net profit margin (TTM)
3.29%
Operating margin (TTM)
3.85%
Effective tax rate (TTM)
24.01%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
3.51%
Return on equity (TTM)
15.99%
Valuation
Price to earnings (TTM)
9.009
Price to revenue (TTM)
0.288
Price to book
1.31
Price to tangible book (TTM)
1.76
Price to free cash flow (TTM)
6.305
Free cash flow yield (TTM)
15.86%
Free cash flow per share (TTM)
3.921
Dividend yield (TTM)
3.06%
Forward dividend yield
3.10%
Growth
Revenue change (TTM)
0.35%
Earnings per share change (TTM)
55.46%
3-year revenue growth (CAGR)
-2.40%
10-year revenue growth (CAGR)
-1.46%
3-year earnings per share growth (CAGR)
0.50%
10-year earnings per share growth (CAGR)
0.96%
3-year dividend per share growth (CAGR)
5.03%
10-year dividend per share growth (CAGR)
-6.45%
What the Analysts think about Macy's
Analyst ratings (Buy, Hold, Sell) for Macy's stock.
Analyst projections of the future price of Macy's stock.
Bulls say / Bears say
Macy’s has delivered five consecutive quarters of comparable-sales growth and beat its Q2 expectations before raising its 2026 sales, comparable-sales and earnings outlook. This suggests the turnaround is translating into broader momentum. (Macy's, Inc., Reuters)
The Reimagine programme appears to be lifting the core Macy’s fleet: renovated stores posted 1.9% Q2 comparable-sales growth, ahead of the Macy’s banner’s 1.1%. Store customer scores have also improved, suggesting the service and merchandising changes are resonating. (Macy's, Inc., CX Dive)
Bloomingdale’s and Bluemercury provide faster-growing premium and beauty businesses: Q2 comparable sales rose 11.3% and 6.2%, respectively, with Bloomingdale’s reaching its highest second-quarter sales in its history. (Macy's, Inc.)
The turnaround remains uneven: Q2 comparable sales at the Macy’s banner rose just 1.1%, well below Bloomingdale’s 11.3%. Reuters reports that the namesake business depends more on value-conscious shoppers, whose spending is under pressure, leaving growth reliant on more resilient premium customers. (Macy's, Inc., Reuters)
Q2 earnings quality received a substantial one-off lift from tariff refunds: about $95 million was added to gross margin, while underlying gross-margin growth was only around 10 basis points. Margin and earnings strength may be harder to repeat when that refund benefit fades. (SEC)
The turnaround may take years to produce meaningful operating leverage: S&P Global Ratings expects higher staffing and selling costs to absorb gross-margin gains, with no meaningful EBITDA-margin improvement until after 2028. That leaves the payoff dependent on sustained sales growth rather than near-term cost leverage. (S&P Global Ratings)
Data summarised monthly by Lightyear AI. Last updated on 15 Oct 2026.
Macy's Financial Performance
Revenues and expenses
Macy's Earnings Performance
Company profitability
Upcoming events
Macy's News
AllArticlesVideos
Funds containing Macy's
AllUSDEURGBP
Fund name | Fund size | $M weighting |
|---|---|---|
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.41% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.19% |
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.19% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.10% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.10% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.